Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial

Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial

Bibliographic Details
Main Authors: Haynes, R, Landray, M, Staplin, N, Spata, E, Peto, L, Knight, M, Mafham, M, Emberson, J, Horby, P
Other Authors: RECOVERY Collaborative Group
Format: Journal article
Language:English
Published: Elsevier 2023

Similar Items